Ernexa Therapeutics, Inc. (ERNA)
12.49
+1.09
(+9.56%)
USD |
NASDAQ |
May 21, 16:00
12.70
+0.21
(+1.68%)
After-Hours: 19:59
Ernexa Therapeutics EPS Diluted (Quarterly) : -6.952 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Quince Therapeutics, Inc. | 3.908 |
| Recursion Pharmaceuticals, Inc. | -0.222 |
| Tango Therapeutics, Inc. | -0.317 |
| Aprea Therapeutics, Inc. | -0.2239 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.506M |
| Total Expenses (Quarterly) | 5.506M |
| Enterprise Value | 4.509M |
| Earnings Yield | -245.9% |
| Normalized Earnings Yield | -230.68 |